The Danish pharmaceutical giant Novo Nordisk has struck an agreement with the Centers for Medicare & Medicaid Services (CMS) to set a negotiated price for

At no point on Thursday did anyone from the administration mention Medicare drug price negotiations, a key part of the Inflation Reduction Act which allows federal officials to negotiate the price of certain drugs. Trump has ridiculed the program, and no Republicans voted for the IRA when it passed in 2022.

Health Affairs' Jeff Byers welcomes Rachel Sachs from Washington University in St. Louis and Deputy Editor Chris Fleming back to the pod to discuss CMS' final guidance for the latest round of the Medicare drug price negotiation program.

The Biden administration is working on forcing the pharmaceutical industry to lower the cost of popular drugs for Medicare Part D recipients. A federal judge has ruled against the pharmaceutical industry in its attempt to get the court to say the Biden ...

WASHINGTON — The Trump administration is expected to announce the results of the second round of Medicare drug-price negotiations soon.

Novo Nordisk said on Wednesday it had agreed a price under the U.S. Medicare scheme for semaglutide, the active ingredient in its key drugs Ozempic and Wegovy, in a deal that some analysts said sounded less onerous than feared.

As the Trump administration begins to make its mark on the Medicare drug price negotiation program and pursue its own policies on prescription drugs, litigation over program continues. In the two years since the first case challenging the program was filed ...